Evidence map›Paper›PMID 10618391›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2000

Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.

A Pandey, A V Podtelejnikov, B Blagoev, X R Bustelo, M Mann, H F Lodish

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
23.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 407 citations in OpenAlex.

  1. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Proteomic Interrogation in Cancer Biomarker.Advances in experimental medicine and biology · 2021
    Article
  11. Article
  12. Article
  13. Advances in development of new tools for the study of phosphohistidine.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
  14. Article
  15. Ablation of Dicer leads to widespread perturbation of signaling pathways.Biochemical and biophysical research communications · 2015
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

A PandeyWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
A V Podtelejnikov
B Blagoev
X R Bustelo
M Mann
H F Lodish
State University of New York · USBrigham and Women's Hospital · USUniversity of Southern Denmark · DK

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1985 to 2021
$38.9M
SIGNAL TRANSDUCTION THROUGH TH ERYTHROPOIETIN RECEPTORK01CA075447 · NCI · JOHNS HOPKINS UNIVERSITY · PI PANDEY, AKHILESH · 1997 to 2001
$319k
NCI NIH HHS K01 CA75447NHLBI NIH HHS P01 HL032262NHLBI NIH HHS P01 HL32262
6 · The paper itself

Abstract

Oligomerization of receptor protein tyrosine kinases such as the epidermal growth factor receptor (EGFR) by their cognate ligands leads to activation of the receptor. Transphosphorylation of the receptor subunits is followed by the recruitment of signaling molecules containing src homology 2 (SH2) or phosphotyrosine interaction domains (PID). Additionally, several cytoplasmic proteins that may or may not associate with the receptor undergo tyrosine phosphorylation. To identify several components of the EGFR signaling pathway in a single step, we have immunoprecipitated molecules that are tyrosine phosphorylated in response to EGF and analyzed them by one-dimensional gel electrophoresis followed by mass spectrometry. Combining matrix-assisted laser desorption/ionization (MALDI) and nanoelectrospray tandem mass spectrometry (MS/MS) led to the identification of nine signaling molecules, seven of which had previously been implicated in EGFR signaling. Several of these molecules were identified from low femtomole levels of protein loaded onto the gel. We identified Vav-2, a recently discovered guanosine nucleotide exchange factor that is expressed ubiquitously, as a substrate of the EGFR. We demonstrate that Vav-2 is phosphorylated on tyrosine residues in response to EGF and associates with the EGFR in vivo. Binding of Vav-2 to the EGFR is mediated by the SH2 domain of Vav-2. In keeping with its ubiquitous expression, Vav-2 seems to be a general signaling molecule, since it also associates with the platelet-derived growth factor (PDGF) receptor and undergoes tyrosine phosphorylation in fibroblasts upon PDGF stimulation. The strategy suggested here can be used for routine identification of downstream components of cell surface receptors in mammalian cells.

Indexed as

Signal TransductionErbB ReceptorsHeLa CellsHumansMass SpectrometryOncogene ProteinsPhosphorylationPhosphotyrosinePrecipitin TestsProtein BindingProto-Oncogene Proteins c-vavReceptor Protein-Tyrosine KinasesReceptors, Platelet-Derived Growth Factorsrc Homology DomainsErbB ReceptorsOncogene ProteinsPhosphotyrosineProto-Oncogene Proteins c-vavReceptor Protein-Tyrosine KinasesReceptors, Platelet-Derived Growth FactorVAV2 protein, human

Identifiers

PMID10618391
PMCPMC26636
OpenAlexW2070066745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.